A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium.

nintedanib eye drop (CBT-001) - Cloudbreak Therap

http://www.ncbi.nlm.nih.gov/pubmed/38883924

Damien F Goldberg; Jinsong Ni; John A Hovanesian; Kenneth N Sall; Olivia L Lee; Rong Yang; Scott M Whitcup

Jun 17, 2024